Dispensing error defence expected to be in effect from April

Dispensing error defence expected to be in effect from April

February 14 2018 The legislative changes designed to decriminalise dispensing errors could come...

Dr Catherine Duggan to move from RPS to be new FIP's chief executive

Dr Catherine Duggan to move from RPS to be new FIP's chief executive

February 9 2018 Dr Catherine Duggan is to take up the position of chief executive of the...

PHE sets out terms of review of prescription medicine dependence

PHE sets out terms of review of prescription medicine dependence

February 2 2018 Details of the review into prescribed medicines that may cause dependence or...

Falsified Medicines Directive update issued for community pharmacy

Falsified Medicines Directive update issued for community pharmacy

February 2 2018 Details of what some of the practical implications of the Falsified Medicines...

NICE consults on role of community pharmacy in promoting health and wellbeing

NICE consults on role of community pharmacy in promoting health and wellbeing

January 23 2018 NICE is consulting on draft guidance on how community pharmacies can promote...

  • Dispensing error defence expected to be in effect from April

    Dispensing error defence expected to be in effect from April

    Wednesday, 14 February 2018 14:32
  • Dr Catherine Duggan to move from RPS to be new FIP's chief executive

    Dr Catherine Duggan to move from RPS to be new FIP's chief executive

    Friday, 09 February 2018 15:07
  • PHE sets out terms of review of prescription medicine dependence

    PHE sets out terms of review of prescription medicine dependence

    Friday, 02 February 2018 14:07
  • Falsified Medicines Directive update issued for community pharmacy

    Falsified Medicines Directive update issued for community pharmacy

    Friday, 02 February 2018 14:03
  • NICE consults on role of community pharmacy in promoting health and wellbeing

    NICE consults on role of community pharmacy in promoting health and wellbeing

    Tuesday, 23 January 2018 12:05

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a department of health building imageSeptember 26 2017

Community pharmacy should be included within the remit of a new body being set up to investigate health service safety, a pharmacy organisation has said.

 The Pharmacists’ Defence Association says any organisation or business, public or private, providing services to the NHS should be included. It is concerned that pharmacy businesses may sometimes put profitability ahead of patient care.

The comments are in response to the Government publishing a draft bill, the Health Service Safety Investigations Bill, which intends to establish a new independent healthcare safety investigation body to improve patient safety.

The Health Service Safety Investigations Body (HSSIB) would have a statutory role, be independent of the NHS and would operate “at arm’s length from Government, with new powers that will enable it to discharge its investigation functions fully and effectively.”

Announcing the Bill, the Government said there are around 24,000 serious incidents of healthcare harm known to occur in the NHS each year; research suggests that around 150 deaths each week could have been avoidable were it not for problems in care.

“This draft Bill is an opportunity to bring about a whole-system change to how the NHS investigates and learns from healthcare error. It will promote transparency and openness, reassuring patients, families and NHS staff that every effort will be made to prevent the same mistakes happening again,” said the Government.

The PDA said that “the HSSIB will have the function of investigating qualifying incidents occurring during the provision of NHS services or occurring at premises at which those services are provided, which should include community pharmacies.”

In addition, the PDA points out that the Health Secretary, Jeremy Hunt, said “When significant errors occur, it is vital that health organisations react quickly and decisively to share lessons and make improvements. To achieve this we need to create an environment where patients, public and healthcare professionals all feel able to speak out about their concerns, without fear or favour.”

The PDA says it believes “it is essential that private organisations that provide NHS services for profit, such as those who provide community pharmacy services, are subject to same level of scrutiny on patient safety as other NHS service providers.”

PDA chief executive Mark Koziol added: “Our members want to provide pharmaceutical services in an environment where patient safety is top priority, but in community pharmacy they can sometimes find their professional responsibilities towards patients at odds with the employers’ drive for profits.

“We want to see the same dramatic improvements in safety that other sectors have achieved through effective investigations bodies. PDA call upon parliamentarians across the political spectrum to ensure this bill includes community pharmacy within the scope of HSSIB.”

Links:
PDA announcement        
Department of Health ‘Health Service Safety Investigations Bill’   

Legal & Policy News

February 22 2018 Community pharmacists in England are being urged to enrol on Masters level training modules with costs covered by the Pharmacy Integration Fund.
February 19 2018 Pharmacists should be receiving educational material this week on a new patient safety campaign from the Centre of Pharmacy Postgraduate Education. Resources have been mailed out ahead...